News | January 09, 2015

Mass General Rolls out Clinical Trial Imaging Tool Powered by Blackford Analysis

Multiple U.S. hospitals implement new tool to enhance quality and accelerate radiologist reporting of clinical trial imaging results for cancer centers

Clinical Trial/Study, Radiation therapy, RSNA 2014, Mass General

Image courtesy of Blackford Analysis

January 9, 2015 — Blackford Analysis announced that its software has been successfully integrated into a tool developed by Massachusetts General Hospital’s Tumor Imaging Metrics Core for its Precision Imaging Metrics system that helps radiologists and oncologists coordinate to generate clinical trial imaging results with enhanced efficiency and quality.

The Precision Imaging Metrics team has implemented Blackford’s MatchedCrosshairs functionality, which enables radiologists to simply click on a location in any scan to instantly bring up the same location on multiple scans from different times and/or different modalities (e.g. CT with MRI).

In addition to internal use, the Mass General’s Precision Imaging Metrics system with the integrated Blackford registration tool has also been rolled out to Cancer Centers at Yale University and the University of Washington in Seattle, and is in the process of being implemented at the Huntsman Cancer Institute at the University of Utah.

For more information: www.blackfordanalysis.com

 

Related Content

New Study Evaluates Head CT Examinations and Patient Complexity
News | Neuro Imaging | May 17, 2019
Computed tomography (CT) of the head uses special X-ray equipment to help assess head injuries, dizziness and other...
New Phase 2B Trial Exploring Target-Specific Myocardial Ischemia Imaging Agent
News | Radiopharmaceuticals and Tracers | May 17, 2019
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Icon Launches New Clinical Trial Patient Engagement Platform
Technology | Patient Engagement | May 14, 2019
Icon plc announced the release of its web-based clinical trial patient engagement platform, to provide patients with...
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Radiation Therapy | May 10, 2019
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients
News | MRI Breast | May 09, 2019
When appropriate, short-interval follow-up magnetic resonance imaging (MRI) can be used to identify early-stage breast...